4/A: McEwen Inc. GC Corrects Stock Option Holdings Post-Split
Insider Transaction Amendment
McEwen Inc.'s General Counsel, Carmen L. Diges, filed an amended Form 4 to correct stock option and common stock holdings following a 10-for-1 reverse stock split.
Summary
- Carmen L. Diges, General Counsel and Corporate Secretary of McEwen Inc., filed an amended Form 4 (Form 4/A).
- The amendment was filed solely to correct previously reported stock option and common stock holdings.
- The correction accounts for the company's 10-for-1 reverse stock split, which became effective on July 28, 2022.
- On September 19, 2025, Diges exercised 21,000 stock options at an exercise price of $1.25 per share.
- Concurrently, Diges sold 21,000 shares of common stock at a weighted average price of $14.3446 per share.
- The sale prices for the common stock ranged from $13.71 to $14.6579 per share.
- Following these transactions, Diges directly beneficially owns 26,096 shares of common stock.
- The exercised stock options were part of a 2020 equity award and vested in three equal annual installments, beginning September 29, 2021.
Sentiment
Score: 6
Explanation: The filing is neutral in terms of company performance, primarily reporting an insider transaction and a correction. The executive realized a significant gain from options, which is positive for the individual, but the sale of shares could be seen as neutral to slightly negative for long-term investor sentiment if not viewed as a standard liquidity event.
Positives
- An executive exercised stock options, indicating a realization of value from their equity compensation.
- The sale price of $14.3446 per share is significantly higher than the exercise price of $1.25, indicating a substantial gain for the executive.
Negatives
- The executive sold all shares acquired through the option exercise, which, while a common practice for liquidity, could be interpreted as a lack of increased long-term conviction in the stock.
- The necessity of filing an amendment suggests an initial reporting error, though it has been corrected.
Future Outlook
This filing is an amendment to an insider transaction report and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.
Management Comments
- The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This amendment is being filed solely to correct the number of stock options and underlying shares of common stock subject to the corresponding 2020 equity award, and the resulting holdings following exercise thereof, to account for the Issuer's 10-for-1 reverse stock split that became effective on July 28, 2022.
Industry Context
This filing pertains to an individual insider transaction and its correction, rather than broader industry trends. It reflects standard executive compensation practices involving stock options and subsequent share sales, which are common across various industries.
Comparison to Industry Standards
- This filing details an executive's exercise of stock options and subsequent sale of shares, a common practice in executive compensation across publicly traded companies.
- The specific details of the transaction, such as the exercise price of $1.25 and sale price of $14.3446, reflect the individual's compensation structure and the company's stock performance relative to the option grant.
- There are no specific comparable companies or projects mentioned in the filing to benchmark against.
Stakeholder Impact
- Shareholders: Provides transparency regarding executive stock transactions and corrections to previously filed information. The sale of shares by an executive might be viewed neutrally or slightly negatively, depending on individual investor interpretation of insider selling.
- Employees: No direct impact mentioned.
- Customers/Suppliers/Creditors: No direct impact mentioned.
Next Steps
- The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon request.
Key Dates
| Date | Description |
|---|---|
| 2021-09-29 | Start date for the vesting of stock options in three equal annual installments. |
| 2022-07-28 | Effective date of McEwen Inc.'s 10-for-1 reverse stock split. |
| 2025-09-19 | Date of stock option exercise and subsequent sale of common stock by Carmen L. Diges. |
| 2025-09-23 | Date of original Form 4 filing. |
| 2025-09-28 | Expiration date of the exercised stock options. |
| 2025-09-29 | Signature date of the amended Form 4/A filing. |
Recommendation
holdThis Form 4/A filing primarily corrects an executive's reported stock option and common stock holdings following a reverse stock split and details a routine exercise-and-sell transaction. While the executive realized a significant gain, the filing does not provide new information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as the filing does not present a compelling reason to alter existing positions based solely on this information.
Keywords
McEwen Inc., MUX, Form 4/A, Insider Trading, Stock Options, Reverse Stock Split, Executive Compensation, Carmen L. Diges, Common Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.